| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |